Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Administration (FDA) inspection for its Unit-2 facility in Raichur, India, with no 483 observations.
IFF Pharma Solutions has announced the launch of Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages.
Berry Global’s presence at this year’s Maghreb Pharma Expo highlights the company’s commitment to supporting growth in emerging healthcare markets across North Africa.
Reading Scientific Services (RSSL) has been awarded the title of ‘Best Performing Professional Services Company of the Year’ at the 2025 ON Awards, hosted by One Nucleus.
BDD has opened its 122m² GMP manufacturing facility at BioCity near Glasgow, following an inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) in March 2025.
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
Beckman Coulter Life Sciences introduces the Next-Generation Basophil Activation Test (BAT) for research use only to more effectively characterise allergies without exposure to potentially harmful allergens.
Vertex Pharmaceuticals has announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a combination regimen with ivacaftor for the treatment of people with cystic fibrosis.
Sensitech, a provider of supply chain visibility solutions, will showcase its suite of solutions at the 25th anniversary edition of LogiPharma, held 8-10th April in Lyon, France.
Aelius Biotech, whose laboratory gut model is used to trial new drugs without the need for animal testing has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
